Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.28 USD | -2.58% | -1.86% | +40.43% |
Apr. 15 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
Apr. 15 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
Business Summary
Number of employees: 83
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Todisco
CEO | Chief Executive Officer | 48 | 22-03-17 |
Mathew David
DFI | Director of Finance/CFO | 47 | 20-05-10 |
Tushar Mukherjee
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
General Counsel | - | Dec. 11 | |
Erin Mistry
PRN | Corporate Officer/Principal | 43 | 19-12-31 |
Frank Raffaele
PRN | Corporate Officer/Principal | - | 22-05-11 |
Donna Ucci
PRN | Corporate Officer/Principal | - | 22-05-11 |
Corporate Officer/Principal | 45 | 18-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Myron Kaplan
CHM | Chairman | 79 | 16-04-26 |
Steven Lefkowitz
DFI | Director of Finance/CFO | 68 | 11-08-14 |
Alan Dunton
BRD | Director/Board Member | 70 | 19-02-28 |
Janet Dillione
BRD | Director/Board Member | 65 | 15-08-05 |
Joseph Todisco
CEO | Chief Executive Officer | 48 | 22-03-17 |
Gregory Duncan
BRD | Director/Board Member | 59 | 20-11-01 |
Robert Stewart
BRD | Director/Board Member | 56 | 23-04-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,981,102 | 54,425,049 ( 98.99 %) | 0 | 98.99 % |
Stock B | 0 | 181,622 | 0 | 0 |
Company contact information
CorMedix, Inc.
300 Connell Drive Suite 4200
07922, Berkeley Heights
+908 517 9500
http://www.cormedix.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.43% | 298M | |
+10.08% | 9.12B | |
-17.63% | 4.8B | |
+0.73% | 3.8B | |
+16.55% | 3.72B | |
+27.76% | 2.58B | |
-26.11% | 2.36B | |
-30.09% | 2.11B | |
+7.15% | 1.86B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- CRMD Stock
- Company CorMedix Inc.